
Dr. Vivek Nandur
Co-Director of the Heritage Fermentations Lab at Arizona State University CEO and Co-Founder of Amara Biosciences

Dr. Vivek Nandur
PhD, University of Toronto
Postdoc, University of Chicago
(239)-989-9816
About
Dr. Vivek Nandur is the Co-Director of the Heritage Fermentations Lab at Arizona State University, where he draws on neuroeconomics, industrial organization, and structural econometrics to examine how commercial incentives drive firms to change product architectures, stripping away ancestral biological signals, which can drive chronic metabolic disease and addiction. His work rests on one claim: dose is not a sufficient statistic for harm. The same molecule can produce different consumption paths and different harm depending on the product architecture and biochemical matrix that deliver it.
Using the tools of economic theory and structural econometrics, he studies product design as an equilibrium outcome. When regulators tax, label and meter a single measured attribute, firms reformulate along the attributes that go unmeasured, and the unpriced dimensions of quality thin out under competition. His papers explore how architecture is chosen when revenue accrues on the continuation margin, why markets under-supply products that help consumers stop, and how we can identify effects of harm in datasets when products with the same dose differ in composition. This leads to a question for public economics: whether a sin good, and therefore a sin tax, can be defined at the category level at all, and what a welfare criterion looks like when the menu itself is endogenous to firm choice.
Education
2024 - Present
University of Chicago, Booth School of Business
Postdoctoral Researcher
2016 - 2023
University of Toronto, Rotman School of Mangement
PhD in Quantitative Marketing
2014 - 2016
University of South Florida, Muma College of Business
MS in Information Systems
2008 - 2012
University of Florida
BA in Economics, Minor in Mathematics
Experience
2024 - Present
Postdoctoral Researcher, The University of Chicago
2023 - Present
Co-Founder, CEO and Chief Scientist, Lumiya Inc.
2023
Senior Data Scientist, Edge
2016 - 2022
Quantitative Researcher, Rotman School of Business
Research
RESEARCH IN PROGRESS
The General Equilibrium Effects of Telehealth (with Jason Gibbons, Neda Laiteerapong, and Jacob Kannarkat)
Improving Measurement In Mental Health (with Robert Gibbons)
Valuing Mental Health Care in Pregnancy (with Catherine Monk)
Has Mass Commercialization Made Alcohol More Toxic?
Can Government Policies Alleviate Smog from Stubble Burning? (with Shreshti Dawat)
WORKING PAPERS
Testing Different Models of Obesity (with Leonard Epstein)
The Complexity of Monetary Incentives: Evidence from the Vaccine Uptake for Covid-19 (Doctoral Thesis)
Media Production and the Attention Economy (Doctoral Thesis)
PUBLICATIONS
Vaccine Hesitancy and Monetary Incentives - Humanities and Social Sciences Communications, (Previously Palgrave Communications) with Ganesh Iyer and David Soberman, 2022 - https://www.nature.com/articles/s41599-022-01074-y
Awards
Interests
OUT OF OFFICE
AMA-Sheth Foundation
Selected as one of the top marketing doctoral students globally for the prestigious AMA-Sheth Foundation Doctoral Consortium, recognizing exceptional research potential and innovative thinking in the field.
Analogue Music
Tennis